Risk factor
Very poor trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex diagnostic testing products for the In-Vitro diagnostics market. The company's products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testing; and the BioCode 2500 analyzer, a system that reads barcoded magnetic beads...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Target Price
The average target price of 6598.TW is 22 and suggests 10% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de
Buy
Sell